CFG
BIIB icon

Clayton Financial Group’s Biogen BIIB Stock Holding History

Clayton Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-97
Closed -$17.8K – 119
2026
Q1 		$17.8K Hold
97
– – 0.01% 194
2025
Q4 		$17.1K Buy
97
+10
+11% +$1.63K 0.01% 201
2025
Q3 		$12.2K Buy
+87
New +$11.8K 0.01% 128

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
NGM
North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Clayton Financial Group's BIIB Position: Q2 2026 in Review

Clayton Financial Group sold out of Biogen (BIIB) in Q2 2026, closing a stake of 97 shares — an estimated $17.8K sold.

Clayton Financial Group first reported a position in BIIB in Q3 2025 and held it in 3 quarters. The position peaked at $17.8K in Q1 2026. 220 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Clayton Financial Group reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 97 Biogen shares in Q2 2026, an estimated $17.8K.
  • Clayton Financial Group first reported a position in Biogen in Q3 2025 and held it in 3 quarters.
  • Clayton Financial Group's Biogen position peaked at $17.8K in Q1 2026.
  • 220 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.